Clinical Trial Update: GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance

View source ↗

Summary

A clinical trial update examining genotypic and phenotypic methods to diagnose HIV-1 resistance to raltegravir by parallel analysis of resistance profiles.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Università Vita-Salute San Raffaele | Conditions: HIV-1 Infected Patients, Fold-change Resistance | Status: UNKNOWN